244 related articles for article (PubMed ID: 30359362)
21. Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.
Dooley KE; Warburton A; McBride AA
mBio; 2016 Sep; 7(5):. PubMed ID: 27624132
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle.
Burley M; Roberts S; Parish JL
Semin Immunopathol; 2020 Apr; 42(2):159-171. PubMed ID: 31919577
[TBL] [Abstract][Full Text] [Related]
25. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
26. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract][Full Text] [Related]
27. Different HPV16 E6/E7 oncogene expression patterns in epithelia reconstructed from HPV16-immortalized human endocervical cells and genital keratinocytes.
Sun Q; Tang SC; Pater MM; Pater A
Oncogene; 1997 Nov; 15(20):2399-408. PubMed ID: 9395236
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional control of human papillomavirus type 18 oncogene expression in different cell lines: role of transcription factor YY1.
Jundt F; Herr I; Angel P; Zur Hausen H; Bauknecht T
Virus Genes; 1995; 11(1):53-8. PubMed ID: 8808335
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.
Bauknecht T; Shi Y
J Virol; 1998 Mar; 72(3):2113-24. PubMed ID: 9499067
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of human DUSP4 gene by cancer-related transcription factors.
Varela T; Conceição N; Laizé V; Cancela ML
J Cell Biochem; 2021 Oct; 122(10):1556-1566. PubMed ID: 34254709
[TBL] [Abstract][Full Text] [Related]
32. Binding of YY1 to the proximal region of the murine beta interferon promoter is essential to allow CBP recruitment and K8H4/K14H3 acetylation on the promoter region after virus infection.
Mokrani H; Sharaf el Dein O; Mansuroglu Z; Bonnefoy E
Mol Cell Biol; 2006 Nov; 26(22):8551-61. PubMed ID: 16954376
[TBL] [Abstract][Full Text] [Related]
33. CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site.
Ralph WM; Liu K; Auborn KJ
J Gen Virol; 2006 Jan; 87(Pt 1):51-59. PubMed ID: 16361417
[TBL] [Abstract][Full Text] [Related]
34. Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16.
Kukimoto I; Kanda T
J Virol; 2001 Oct; 75(19):9302-11. PubMed ID: 11533193
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M
J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CTCF loop formation during pancreatic cell differentiation.
Lyu X; Rowley MJ; Kulik MJ; Dalton S; Corces VG
Nat Commun; 2023 Oct; 14(1):6314. PubMed ID: 37813869
[TBL] [Abstract][Full Text] [Related]
37. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M; Dong XP; Beyer-Finkler E; Stubenrauch F; Fuchs PG; Pfister H
EMBO J; 1994 Mar; 13(6):1460-6. PubMed ID: 8137827
[TBL] [Abstract][Full Text] [Related]
38. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
Chandnani N; Gupta I; Thakkar V; Sarkar K
Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.
Yukawa K; Butz K; Yasui T; Kikutani H; Hoppe-Seyler F
J Virol; 1996 Jan; 70(1):10-6. PubMed ID: 8523512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
